CD8A and hepatocellular carcinoma: For example, an allosteric inhibitor (KH3) of phosphoglycerate mutase 1 (PGAM1) promotes HCC ferroptosis, increases the number of tumor-infiltrating CD8+ T cells, and enhances the efficacy of anti-PD-1 immunotherapy in HCC [117].